CEWG January 09 Full Report - National Institute on Drug Abuse

Section IV. Across <strong>CEWG</strong> Areas: Treatment Admissions, Forensic Laboratory Analysis Data, and Average Drug Price and Purity Data
Club Drugs (MDMA, GHB/GBL, LSD, Ketamine)
Treatment Admission Data on
Club Drugs
The club drugs reported on in this section include
MDMA (methylenedioxymethamphetamine, or
ecstasy), GHB (gamma hydroxybutyrate), GBL
(gamma butyrolactone), LSD (lysergic acid diethylamide),
and ketamine. Admissions for primary
treatment of club drugs or MDMA are not captured
in all treatment data systems, but they appear
low in those areas that do report on these drugs.
Forensic Laboratory Data on Club Drugs
MDMA. MDMA was the club drug most frequently
reported among NFLIS data in the 22
<strong>CEWG</strong> areas depicted in table 12. As shown,
MDMA equaled or exceeded 2 percent of all drug
items in 11 areas. These include Atlanta and San
Francisco, which had the highest percentage (3.8
percent each), followed by Detroit (3.7 percent),
Minneapolis/St. Paul (3.6 percent), and Seattle
(3.2 percent). Others in this group were St. Louis,
Los Angeles, Honolulu, Denver, Washington, DC,
and San Diego (table 12). As shown in section II,
table 1, MDMA was the third most frequently
identified drug item in Atlanta, and it ranked
fourth in Chicago, Minneapolis/St. Paul, and
Honolulu in the first half of 2008.
GHB. GHB items were reported among the
forensic laboratory data in 10 <strong>CEWG</strong> areas: Boston,
Chicago, Los Angeles, New York City, San
Diego, San Francisco, Seattle, St. Louis, Texas,
and Washington, DC. These items accounted for
much less than 1 percent of all items in all reporting
areas. GHB was not among the top 10 drugs
reported from any <strong>CEWG</strong> area (table 13 and section
II, table 1).
LSD. LSD was reported in the forensic laboratory
data among drug items identified for 17
<strong>CEWG</strong> metropolitan areas. None, however, had
30 or more cases. LSD was not among the top 10
drugs reported for any <strong>CEWG</strong> reporting area, and
no LSD items were reported from Albuquerque,
Detroit, Honolulu, Phoenix, and Washington, DC
(table 13 and section II, table 1).
Ketamine. Ketamine items were reported
among drug items identified from all except 5
of 22 <strong>CEWG</strong> areas during the first half of 2008.
While ketamine represented less than 1 percent of
total drug items identified in any reporting area,
four areas reported 30 cases or more: Texas, New
York City, Los Angeles, and Atlanta (table 13).
Ketamine did not figure among the top 10 most
frequently identified drug items in any <strong>CEWG</strong>
area (section II, table 1).
Proceedings of the Community Epidemiology Work Group, <strong>January</strong> 20<strong>09</strong> 95